Simris Group AB
Pioneering next-generation ADC payloads using proprietary cyanobacterial science.
Oversikt
- 5–9
- Ansatte
- 150–199t SEK
- Omsetning
- 2011
- Grunnlagt
Beskrivelse
Simris is a biotechnology company dedicated to revolutionizing cancer treatment through its proprietary pipeline of next-generation ADC payloads. These payloads are born from world-class cyanobacterial science, proprietary conjugation methods, and collaborations with leading research institutions. T...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Fiskodling i saltvatten
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556841918701
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Nanohumps Biosciences Oy
Pioneering revolutionary cancer therapies using proprietary nanosized antibodies.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Xbrane Biopharma AB
20–49 ansatteDeveloping cost-effective biosimilars using proprietary platform technology.
Alvotech Sweden AB
20–49 ansatteDeveloping and manufacturing affordable biosimilars to expand global medicine access.
Abarceo Pharma AB
5–9 ansatteDeveloping novel small molecule therapeutics targeting VDAC1 for diabetes.
Utforsk mer
Spørsmål om Simris Group AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo